Quick Answer
CorMedix Inc. reported Total Assets of $826.14 million for the year ending 2025.
- CorMedix Inc. showed an increase of +595.1% in Total Assets from 2024 to 2025.
- This data is from CorMedix Inc.'s annual report (Form 10-K), filed with the SEC on March 5, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $4.95 million | Q3 2011: $3.03 million | Q1 2012: $2.04 million | Q3 2012: $1.26 million | Q1 2013: $967.6 thousand | Q2 2013: $395.1 thousand | Q3 2013: $1.04 million | Q1 2014: $9.76 million | Q2 2014: $8.26 million | Q3 2014: $6.85 million | Q1 2015: $9.75 million | Q2 2015: $38.80 million | Q3 2015: $39.31 million | Q1 2016: $33.61 million | Q2 2016: $31.21 million | Q3 2016: $28.84 million | Q1 2017: $14.93 million | Q2 2017: $21.16 million | Q3 2017: $13.93 million | Q4 2017: $13.45 million | Q1 2018: $9.61 million | Q2 2018: $5.93 million | Q3 2018: $8.05 million | Q1 2019: $27.31 million | Q2 2019: $27.56 million | Q3 2019: $33.72 million | Q1 2020: $27.40 million | Q2 2020: $24.24 million | Q3 2020: $40.02 million | Q1 2021: $84.26 million | Q2 2021: $80.86 million | Q3 2021: $75.39 million | Q1 2022: $64.93 million | Q2 2022: $67.75 million | Q3 2022: $62.08 million | Q1 2023: $59.23 million | Q2 2023: $57.03 million | Q3 2023: $91.43 million | Q1 2024: $68.02 million | Q2 2024: $57.73 million | Q3 2024: $77.59 million | Q1 2025: $149.58 million | Q2 2025: $252.60 million | Q3 2025: $750.86 million.
- Over the full 16 years of available data (2010 to 2025), CorMedix Inc.'s Total Assets has grown by 9,237.3%.
- Historical annual values: Fiscal year 2025: $826.14 million | Fiscal year 2024: $118.85 million | Fiscal year 2023: $82.06 million | Fiscal year 2022: $62.04 million | Fiscal year 2021: $68.95 million | Fiscal year 2020: $49.31 million | Fiscal year 2019: $29.48 million | Fiscal year 2018: $18.83 million | Fiscal year 2017: $13.45 million | Fiscal year 2016: $21.91 million | Fiscal year 2015: $37.10 million | Fiscal year 2014: $5.10 million | Fiscal year 2013: $2.97 million | Fiscal year 2012: $1.15 million | Fiscal year 2011: $2.56 million | Fiscal year 2010: $8.85 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: